Article
Publicly Available
Frontmatter
Published/Copyright:
March 15, 2023
Published Online: 2023-03-15
Published in Print: 2023-03-28
©2023 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Highlight: Chemical Biology of Ion Channels
- Highlight: chemical biology of ion channels
- The second PI(3,5)P2 binding site in the S0 helix of KCNQ1 stabilizes PIP2-at the primary PI1 site with potential consequences on intermediate-to-open state transition
- In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs
- A novel NMDA receptor test model based on hiPSC-derived neural cells
- Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol – starting point for PET tracer development
- Characterization of Kv1.2-mediated outward current in TRIP8b-deficient mice
- Influence of inflammatory processes on thalamocortical activity
- NMDA receptors – regulatory function and pathophysiological significance for pancreatic beta cells
- The role of the Na+/Ca2+-exchanger (NCX) in cancer-associated fibroblasts
- Pancreatic KCa3.1 channels in health and disease
- Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammation
Articles in the same Issue
- Frontmatter
- Highlight: Chemical Biology of Ion Channels
- Highlight: chemical biology of ion channels
- The second PI(3,5)P2 binding site in the S0 helix of KCNQ1 stabilizes PIP2-at the primary PI1 site with potential consequences on intermediate-to-open state transition
- In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs
- A novel NMDA receptor test model based on hiPSC-derived neural cells
- Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol – starting point for PET tracer development
- Characterization of Kv1.2-mediated outward current in TRIP8b-deficient mice
- Influence of inflammatory processes on thalamocortical activity
- NMDA receptors – regulatory function and pathophysiological significance for pancreatic beta cells
- The role of the Na+/Ca2+-exchanger (NCX) in cancer-associated fibroblasts
- Pancreatic KCa3.1 channels in health and disease
- Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammation